(secondQuint)Fontan Udenafil Exercise Longitudinal Assessment Trial.

 This study is a randomized, double-blinded, efficacy trial of the effects of udenafil vs.

 placebo on the background of standard therapy on maximal VO2 (ml/kg/min) from baseline to six months in adolescent survivors of the Fontan procedure.

 .

 The target sample size is 400 subjects (200 per group).

.

 Fontan Udenafil Exercise Longitudinal Assessment Trial@highlight

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent subjects who have undergone the Fontan procedure.

